Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,200
Closed -$124K 942
2023
Q3
$124K Buy
+1,200
New +$134K 0.01% 787

Other funds holding MRNA

MGO One Seven's MRNA Position: Q2 2026 in Review

MGO One Seven opened a new position in Moderna (MRNA) in Q2 2026: 3,153 shares worth $221K. The stake represents ﹤0.01% of the portfolio and ranks #1431 among its holdings. This is a return to the name: MGO One Seven previously reported a position in MRNA as recently as Q3 2024.

MGO One Seven first reported a position in MRNA in Q2 2021 and has held it in 8 quarters since. The position peaked at $401K in Q2 2024. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • MGO One Seven held 3,153 shares of Moderna worth $221K as of Q2 2026.
  • Moderna was a new MGO One Seven position in Q2 2026.
  • Moderna made up ﹤0.01% of MGO One Seven's portfolio in Q2 2026, its #1431 holding.
  • MGO One Seven first reported a position in Moderna in Q2 2021 and has held it in 8 quarters since.
  • MGO One Seven's Moderna position peaked at $401K in Q2 2024.
  • 782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on MGO One Seven's 13F filing for Q2 2026, filed 31 Jul 2026.